Clin2
NCT07705074Likely a fitNot yet recruiting

FAPI PET imaging study for cancer and other diseases

Thyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract TumorSarcoidosisThyroid CancerBreast CancerHepatocellular Carcinoma (HCC)Gastric Cancer (GC)

Part of Blood & lymphatic, Cancer, Digestive system, Heart & circulation, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.

This study uses a special type of PET scan called FAPI PET to see if it can help detect or monitor cancer and other diseases. It is for people who already need a PET or CT/MRI scan as part of their standard care.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
770 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have or might have cancer or another condition that requires imaging.
  • You are already scheduled for a standard scan like a PET, CT, or MRI.
  • You are not pregnant or breastfeeding.
  • You can lie still for the scan and do not have severe claustrophobia.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06916338Recruiting
PET imaging study using 18F-FAPI-04 for breast cancer

This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.

Qingdao, Shandong
NCT06503146Recruiting· Phase 2
New imaging tracer for detecting various cancers

This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.

Bethesda, Maryland
NCT06937112Recruiting
A new scan for early detection of certain cancers

This trial tests a new imaging agent (18F-FAPI) to see if it can help find tumors early in people with lung, thyroid, pancreatic, melanoma, or neuroendocrine cancers.

Nanjing, Jiangsu
NCT07128277Not yet recruiting
FAPI PET imaging for spotting cancer spread

This study tests a new type of PET scan that uses a special tracer called FAPI to find where cancer has spread in your body. It may help doctors see hidden tumors more clearly without needing extra treatments first.

Chongqing, Chongqing Municipality
NCT06688071Recruiting
FAPI PET/CT scan for people with cancer

This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.

Tianjin, Tianjin Municipality
NCT07776899Recruiting
FAPI PET scans for solid tumors

This study uses a special PET scan called FAPI to help find or monitor solid tumors. It may help doctors see tumors more clearly and guide treatment decisions.

Shanghai

Hear when a new Head and Neck Cancer (H&N) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.